GI Windows Surgical
PrivateLast Round
Series B
Nov 15, 2024
Total Funding Raised
$68M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GI Windows Surgical operates in Healthcare & Life Sciences and is based in Westwood, Massachusetts. Its latest recorded funding round was a Series B round in November 2024.
GI Windows Surgical is a clinical-stage medical device company that develops novel magnetic anastomosis technology to enable less invasive surgical procedures for conditions such as obesity and type-2 diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GI Windows Surgical Comparables
Compare GI Windows Surgical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GT Metabolic Solutions | 92% | |
| USGI Medical | 85% | |
| Morphic Medical | 82% |
For institutional investors. Book with your work email.
GI Windows Surgical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 15, 2024 | ||||
| Series A Extension | Aug 19, 2020 | ||||
| Series A | Dec 11, 2019 |
For institutional investors. Book with your work email.
GI Windows Surgical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orlando Health Ventures | Series B |
| GT Healthcare Capital Partners | Series A Extension, Series A |
| Johnson & Johnson Innovation – JJDC | Series B, Series A Extension |
| The Kennedy Trust for Rheumatology Research | Series A Extension |
| Johnson & Johnson Innovation - JJDC, Inc. | Series B, Series A Extension |
| Sonder Capital | Series A Extension, Series A |
| JCInvestco | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 26, 2026
Grew 20% QoQ, from 35 to 42 employees.
- Jul 25, 2026
Grew 21% QoQ, from 33 to 40 employees.
For institutional investors. Book with your work email.
GI Windows Surgical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GI Windows Surgical's valuation, stock price, and market status.
Is GI Windows Surgical a public or private company?
GI Windows Surgical is a private company.
What is the current stock price of GI Windows Surgical?
GI Windows Surgical is a private company, so its shares have no public market price. Caplight tracks GI Windows Surgical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GI Windows Surgical worth (valuation)?
Valuation information for GI Windows Surgical is not publicly available.
Can I buy GI Windows Surgical stock?
GI Windows Surgical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GI Windows Surgical's last funding round?
GI Windows Surgical's most recent funding round was Series B on November 15, 2024.
Who are the main investors in GI Windows Surgical?
Key investors in GI Windows Surgical include Orlando Health Ventures, GT Healthcare Capital Partners, Sonder Capital.
Will GI Windows Surgical IPO soon?
No public IPO plans have been announced for GI Windows Surgical.
How can I track GI Windows Surgical secondary market activity?
Caplight tracks bids, offers, and trades in GI Windows Surgical's shares on secondary markets.